Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Velia Therapeutics
Late Model Lab Equipment from Velia Therapeutics: Mass Specs, Sequencers, PCR Machines, Chromatography Systems & More! San Diego, CA.

Starting: Mar 18th, 2025 7:00am PDT

Ending: Mar 21st, 2025 9:00am PDT

Immediately Accepting Bids
Engine Bio
Late Model Lab Equipment Surplus to the Needs of Engine Bio: NMR, Microscopes, Ultracentrifuges! Redwood City, CA.

Starting: Mar 19th, 2025 7:00am PDT

Ending: Mar 20th, 2025 10:00am PDT

Immediately Accepting Bids
Bavarian Nordic
Premium Lab Equipment from Bavarian Nordic: HPLCs, PCR, Liquid Handlers, Chromatography Systems & More! San Diego, CA.

Starting: Mar 18th, 2025 7:00am PDT

Ending: Mar 19th, 2025 9:00am PDT

Immediately Accepting Bids
Ensoma
Late Model Lab Equipment Surplus to Future Operations of Ensoma: Flow Cytometers, Shaker Incubators, PCR Machines & More! Copenhagen, Denmark.

Starting: Mar 4th, 2025 7:00am CEST

Ending: Mar 18th, 2025 10:00am CEST

Immediately Accepting Bids
PSS
Biotech & Pharma Lab Equipment from Global Sellers: HPLCs, Mass Specs, Analyzers, Centrifuges & More! Multiple Locations, US.

Starting: Mar 4th, 2025 7:00am PDT

Ending: Mar 5th, 2025 9:00am PDT

Immediately Accepting Bids
Cosette
Transdermal Lab Equipment from a Dermatology Pharma Leader: Diffusion Cell Systems, HPLCs, Rheometers & More! Bridgewater, NJ.

Starting: Feb 18th, 2025 7:00am EDT

Ending: Feb 19th, 2025 12:00pm EDT

Immediately Accepting Bids
Amneal
Pharma Solid Dose Processing Equipment Surplus from Amneal: Granulators, Capsule Fillers, Fluid Bed Dryers & More! Multiple Locations, NJ.

Starting: Feb 11th, 2025 7:00am EDT

Ending: Feb 12th, 2025 12:00pm EDT

Immediately Accepting Bids
Achilles Therapeutics
Phenomenal Offering of Late Model R&D Equipment from Achilles Therapeutics: Flow Cytometers, Analyzers, PCR Systems & More! United Kingdom.

Starting: Jan 26th, 2025 9:00am BST

Ending: Feb 12th, 2025 10:00am BST

Immediately Accepting Bids
Federal Inventory Reduction
Processing & Manufacturing Equipment from the World’s Largest Pharma Equipment Dealer: Capsule Fillers, Tablet Presses & More! Cleveland, OH.

Starting: Jan 21st, 2025 7:00am EDT

Ending: Jan 22nd, 2025 12:00pm EDT

Immediately Accepting Bids
MabPlex USA
State-of-the-Art Biopharma Equipment from MabPlex USA: Late-Model Bioreactors, Chromatography Skids & More! San Diego, CA.

Starting: Jan 20th, 2025 7:00am PDT

Ending: Jan 21st, 2025 9:00am PDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.